S100A14 and neoplasm: Notably, low S100A14 expression was significantly more prevalent in advanced TNM stages, particularly stage IV, suggesting that reduced S100A14 expression may be associated with tumor progression and metastasis. Supporting this, Wang et al. found lower S100A14 levels in malignant tissues compared to normal tissues, with reduced expression in poorly differentiated tumors and cases with distant metastases.